International Journal of Surgical Oncology / 2012 / Article / Tab 7

Research Article

Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer

Table 7

Prognostic parameters (results of Cox proportional hazard model and logrank test).

Cox hazard modelLogrank test
X 2 Realtive sisk95% CIX 2

Sex (male versus female)2.1580.1410.6520.3697–1.15314.2980.038
Age (≤65 versus >65)0.6030.4371.3990.5991–3.26920.2890.59
Histologic type (diff. versus poorly)0.0240.8761.1710.1584–8.66510.6310.427
CC (CC-0 versus CC-1)4.1970.042.0051.0306–3.90418.5370.003
PCI (≥6 versus ≤7)1.5920.2061.5280.7908–2.95365.7370.017
Pathologic response on PC (Ef-1, -2 versus Ef-2, -3)4.2690.0380.4290.1927–0.957510.3030.001
LN status (pN0 versus pN1, 2, and 3)2.4780.1152.1210.8317–5.41083.7390.053
Cytology after NIPS (class I versus class V)0.0470.8281.0790.5415–2.15130.3650.546

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.